Archive

Kevin O'Regan to lead PartnerRe's push into worldwide longevity markets

Reinsurance executive is appointed CEO for global longevity

MetLife and Zurich complete £340m longevity swap with UK pension fund

Lloyd's and Cambridge risk experts publish pandemic scenario with $41.7trn economic loss

Farsight Partners to advise AB CarVal on sourcing $1bn of life and health financing deals

Firm led by former members of Securis's life team

Life insurance market to surge globally, says Swiss Re report

Sector will have to navigate worrying trends in life expectancy, reinsurer warns

Mortality rates for young adults remain high, CMI reports

LCP raises questions on Dutch mortality projection model

Methodology has significant impact on pension liabilities and risk transfer pricing

Apra sounds out Australia's life firms about increasing longevity products

Japan's insurers preparing to accept more cancer-related risks

S&P Global Ratings says market enjoys high and stable profit margins

Re/insurers consider a different outcome from cancer

Once a probable death knell, a cancer diagnosis is increasingly becoming a chronic disease, thanks to advances in testing and treatment. This has significant implications for life and health re/insurers, as David Walker reports